Money & Company

Tracking the market and economic trends
that shape your finances.

« Previous Post | Money & Company Home | Next Post »

Video: David Lazarus on a tough choice for diabetics

December 7, 2010 | 10:32 am

UnitedHealthcare is raising the price of NovoLog by 250% while lowering the price of a similar drug, Humalog. The shift will force those on NovoLog to make difficult choices, consumer columnist David Lazarus says, and also shows how out of whack the healthcare system is.

Here's a link to David's columns.

--Pat Benson